Latest News

Experimental antibody shows early promise for treatment of childhood tumor

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody. Four patients are still alive after more than two-and-a-half years and without additional treatment. Neuroblastoma is a cancer of the sympathetic nervous system. It is the most common cancer diagnosed in the first year of life and accounts for 7 to 10 percent of childhood cancers.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Universal helmet laws reduce traumatic brain injuries in young motorcyclists, according to trauma surgeons

  • Potential treatment target for cocaine addiction identified by study

  • New discovery could lead to more targeted head and neck cancer therapies

  • New molecule sneaks medicines across blood-brain barrier

  • One hormone, Two roles: Sugars differentiate seasonality, metabolism

  • For stroke patients, hospital bed position is delicate balancing act

  • Novel tinnitus therapy helps patients cope with phantom noise

  • People change their moral values to benefit themselves over others

  • Digital Therapist: Computer program analyzes speech, mental health

  • High prevalence of vitamin D deficiency across the board in neuromuscular disease

  •